9 search results found
-
Past Deadline: Mar 30, 2024
Speak at the 2024 Bioplus Interphex Korea & Japan Seminar
speakerThe Startup Exchange team is looking for 4 Startups to present and exhibit at the two events, In Seoul and Tokyo.
-
Decoy Therapeutics Inc.
Cambridge, MAThe 21st century is experiencing epidemics and pandemics with increasing frequency, and the world needs new tools to combat these diseases. Decoy's platform engineers new pan-viral drugs that address both existing and new zoonotic viral threats. Our lead antiviral nasal spray has demonstrated... MoreKeywords:
-
Kytopen Corporation
Cambridge, MAKytopen is developing platforms to accelerate the discovery and manufacturing of next-generation cell & gene therapies. The Flowfect technology offers a scalable, non-viral solution to deliver genetic payloads to cells in order to augment their functionality. The technology also enables continuous... MoreKeywords:
-
Past Deadline: Mar 31, 2023
The Fujitsu Quantum Simulator Challenge
partnershipFujitsu Limited(“Fujitsu”) would like to solicit applications from interested members of the industry and academia to test the quantum simulator on novel problems and applications.
-
Past Deadline: Mar 4, 2022
Takeda Seeks Startups working on 4 therapeutic areas
partnershipTakeda is looking for new approaches and technologies that can help them address challenges/opportunities in gastroenterology, oncology, neuroscience and rare genetic & hematology.
-
Synthetic Biology Workshop 2017 - Academic Keynote - Innovations in Synthetic Biology
James J. Collins, Termeer Professor of Medical Engineering & Science, MIT & co-founder of Enbiotix, Synlogic, and multiple other startups fostered in the Collins lab, including Sample6.
-
-
Synthetic Biology Workshop 2017 - Panel Discussion
Synthetic Biology Workshop 2017 - Panel Discussion
-
The Future of Energy Innovation - Industry View
Dave Truch, Technology Director, Digital Innovation Organization, BP
